Journal of Receptor, Ligand and Channel Research

Titel Veröffentlichungsdatum Sprache Zitate
Alcaftadine, a new antihistamine with combined antagonist activity at histamine H1, H2, and H4 receptors2012/12/01English2
Pharmacophore modeling: advances, limitations, and current utility in drug discovery2014/11/01English2
Overview of the LDL receptor: relevance to cholesterol metabolism and future approaches for the treatment of coronary heart disease2009/12/01English2
The role of sigma-1 receptors in the pathophysiology of neuropsychiatric diseases2009/12/01English2
Pharmacological characterization of oxime agonists of the histamine H4 receptor2009/12/01English2
ATP8A1 activity and phosphatidylserine transbilayer movement2008/09/01English2
Hydrophobicity profiles in G protein-coupled receptor transmembrane helical domains2010/12/01English1
Phosphodiesterase inhibition in the treatment of autoimmune and inflammatory diseases: current status and potential2014/12/01English1
Structure-based three-dimensional pharmacophores as an alternative to traditional methodologies2014/06/01English1
Programmed death-1/programmed death-1 ligand axis as a therapeutic target in oncology: current insights2014/12/01English1
Sialic acid receptors: focus on their role in influenza infection2018/04/01English
Interaction of recombinant and native Cav2.3 E-/R-type voltage-gated Ca2+ channels with the molecular chaperone Hsp70 [Corrigendum]2014/01/01English
Role of calcitonin gene-related peptide and brain natriuretic peptide to modulate the excitability state of trigeminal neurons: relevance to migraine pathology and treatment2015/01/01English
The AMPA receptor as a therapeutic target in epilepsy: preclinical and clinical evidence2014/09/01English
Adenosine A2a receptor agonists as regulators of inflammation: pharmacology and therapeutic opportunities2009/08/01English
NMDA-gated ion channel research and its therapeutic potentials in neurodegenerative diseases: a review2009/11/01English
Nucleic acid recognizing Toll-like receptors as therapeutic targets: a focus on autoimmunity and cancer2009/08/01English
Autoantibodies, human Fcγ receptors, and autoimmunity2009/11/01English
GIRK2 and neuronal pattern of generation and settling in homozygous <em>weaver</em> mice2009/10/01English
Nedd4-2 regulation of voltage-gated ion channels: an update on structure&ndash;function relationships and the pathophysiological consequences of dysfunction2015/08/01English
Liposome mitigation of curcumin inhibition of cardiac potassium delayed-rectifier current2012/11/01English
Glutamate pathway implication in amyotrophic lateral sclerosis: what is the signal in the noise?2010/12/01English
Ligand competition assays indicate allosterism and insufficiency of the ternary complex model2010/07/01English
Creatine supplementation upregulates excitation-contraction coupling in C2C12 myotubes2010/05/01English
Dominant negative effect of the extracellular domain of CASR2009/12/01English
Incretins and the specific mechanism of action of liraglutide, the first applicable human glucagon-like peptide 1 analog in the treatment of type 2 diabetes2010/09/01English
Tachykinins and neurokinin receptors in bone marrow functions: neural-hematopoietic link2010/04/01English
Effects of extracts from Cordyceps sinensis on M1 muscarinic acetylcholine receptor in vitro and in vivo2010/08/01English
Modularity in receptor evolution: insulin- and glucagon-like peptide modules as binding sites for insulin and glucose in the insulin receptor2010/07/01English
Specific mechanism of action of amisulpride in the treatment of schizophrenia and correlation with clinical response and tolerability2011/08/01English